首页|长链非编码RNA DLG相关蛋白1-AS5在乳腺癌组织中的表达及对癌细胞增殖和侵袭的影响

长链非编码RNA DLG相关蛋白1-AS5在乳腺癌组织中的表达及对癌细胞增殖和侵袭的影响

扫码查看
目的 分析长链非编码RNA(lncRNA)DLG相关蛋白(DLGAP)1-AS5对乳腺癌细胞增殖、侵袭的影响及其分子机制。方法 采用癌症基因组图谱(TCGA)数据库分析乳腺癌组织及正常组织中DLGAP1-AS5表达水平,观察DLGAP1-AS5表达水平与乳腺癌患者生存期的关系。采用实时荧光定量PCR(qRT-PCR)检测4种乳腺癌细胞系:永生化乳腺上皮细胞(MCF-10A)、人乳腺癌细胞(MCF-7、HCC-1937)、人乳腺腺癌细胞(SK-BR-3)、人乳腺管癌细胞(BT-549)中DLGAP1-AS5表达水平。将DLGAP1-AS5过表达质粒或阴性对照质粒转染至MCF-7细胞,计为DLGAP1-AS5组和阴性对照组。采用四甲基偶氮唑盐比色法(MTT)和Transwell实验检测MCF-7细胞的增殖和侵袭情况。采用starBase v3。0在线软件和双荧光素酶报告实验检测DLGAP1-AS5和miR-362-5p的靶向关系。qRT-PCR检测MCF-7细胞中miR-362-5p表达水平。蛋白质印迹实验检测MCF-7细胞中p38-丝裂原活化蛋白激酶(MAPK)信号通路蛋白表达水平。结果 与正常组织比较,乳腺癌组织中DLGAP1-AS5表达水平降低(P<0。01)。与DLGAP1-AS5表达较低的乳腺癌患者比较,DLGAP1-AS5表达较高的乳腺癌患者总生存期和无病生存期均较长(P均<0。01)。与MCF-10A比较,乳腺癌细胞系中DLGAP1-AS5表达降低(P<0。01),MCF-7细胞中DLGAP1-AS5表达降低最明显(P<0。01)。与阴性对照组比较,过表达DLGAP1-AS5后MCF-7细胞增殖能力减弱(P<0。05),细胞侵袭能力降低(P<0。01)。DLGAP1-AS5能够靶向结合miR-362-5p(P<0。01)。与阴性对照组比较,过表达DLGAP1-AS5后MCF-7细胞中miR-362-5p表达降低(P<0。01),p38-MAPK信号通路蛋白表达降低(P<<0。01)。结论 DLGAP1-AS5在乳腺癌组织和细胞系中低表达,其表达水平与乳腺癌患者生存期相关。过表达DLGAP1-AS5可通过下调miR-362-5p表达抑制乳腺癌MCF-7细胞的增殖和侵袭。
Expression of lncRNA DLGAP1-AS5 in breast cancer tissue and its effect on proliferation and invasion of breast cancer cells
Objective To explore the effect of long non-coding RNA(lncRNA)DLGAP1-AS5 on the prolif-eration and invasion of breast cancer cells and its molecular mechanism.Methods The TCGA database was used to analyze the expression level of DLGAP1-AS5 in breast cancer tissues and normal tissues,and to observe the re-lationship between the expression level of DLGAP1-AS5 and the survival period of breast cancer patients.The ex-pression level of DLGAP1-AS5 in four breast cancer cell lines:immortalized breast epithelial cells(MCF-10A),human breast cancer cells(MCF-7,HCC-1937),human breast adenocarcinoma cells(SK-BR-3),and human breast tube cancer cells(BT-549)was detected by qRT PCR.The DLGAP1-AS5 overexpression plasmid or negative con-trol plasmid was transfected into MCF-7 cells,which were designated as DLGAP1-AS5 group and NC group,re-spectively.The proliferation and invasion of MCF-7 cells were detected by MTT and Transwell assays.The target-ing relationship between DLGAP1-AS5 and miR-362-5p was detected by starBase v3.0 online software and dual luciferase reporter assay.The expression level of miR-362-5p in MCF-7 cells was detected via qRT-PCR.Addi-tionally,the proteins expression of the p38-MAPK signaling pathway in MCF-7 cells was detected by western blotting.Results Compared with normal tissues,the expression level of DLGAP1-AS5 in breast cancer tissues was lower(P<0.01).Breast cancer patients with lower DLGAP1-AS5 expression demonstrated significantly longer overall survival and disease-free survival compared to those with higer DLGAP1-AS5 expression level(P<0.01).When compared to MCF-10A,the expression of DLGAP1-AS5 was notably downregulated in breast cancer cell lines(P<0.01).Among these cell lines,the reduction in DLGAP1-AS5 expression was most pronounced in MCF-7 cells(P<0.01).Compared with the NC group,overexpression of DLGAP1-AS5 weakened the proliferation ability of MCF-7 cells(P<0.05)and decreased their invasive ability(P<0.01).DLGAP1-AS5 could target and bind miR-362-5p(P<0.01).Compared with the NC group,overexpression of DLGAP1-AS5 led to a significant reduction in miR-362-5p expression(P<0.01)and a notable downregulation of p38-MAPK signaling pathway proteins in MCF-7 cells(P<0.01).Conclusion DLGAP1-AS5 is expressed at low levels in breast cancer tissues and cell lines,and its expression level is closely associated with the survival period of breast cancer patients.Overexpression of DLGAP1-AS5 can effectively inhibit the proliferation and invasion of breast cancer MCF-7 cells by downregulating the expression of miR-362-5p.

Breast neoplasmsRNA,long noncodingCell proliferationCell invasion

陆凯、陆建菊、郭文利、黄建棋

展开 >

嘉兴市第一医院乳腺病科,浙江嘉兴 314001

乳腺肿瘤 RNA,长链非编码 细胞增殖 细胞侵袭

浙江省嘉兴市科技计划项目

2020AD30066

2024

中国药物与临床
中国医院协会

中国药物与临床

影响因子:0.846
ISSN:1671-2560
年,卷(期):2024.24(2)
  • 19